Ascend Wellness Holdings Azioni (OTC: AAWH)

Ultime notizie per Ascend Wellness Holdings (OTC:AAWH) Azioni

Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.

ASCEND WELLNESS HOLDNGS A by Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings Inc

UBS analyst Mauricio Serna maintains Dillard's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDS#NYSE">DDS</a>) with a Sell and raises the price target from $200 to $202.

News

Price Target

Analyst Ratings

UBS Maintains Sell on Dillard's, Raises Price Target to $202

UBS analyst Jay Sole maintains Kontoor Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KTB#NYSE">KTB</a>) with a Buy and lowers the price target from $108 to $96.

UBS Maintains Buy on Kontoor Brands, Lowers Price Target to $96

Macro Economic Events

Global

Economics

Market Vectors Rare Earth/Strategic Metals Etf

REMX

Senior White House Official Says Press Conference With Zelenskiy Canceled; No Deal Signed; Says "It's Up To Ukrainians If It Can Be Rescheduled While Zelenskiy Still In Country"

Wells Fargo analyst Jonathan Reeder maintains SJW Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NASDAQ">SJW</a>) with a Equal-Weight and raises the price target from $53 to $57.

Wells Fargo Maintains Equal-Weight on SJW Gr, Raises Price Target to $57

Wells Fargo analyst Steven Cahall maintains Cable One (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CABO#NYSE">CABO</a>) with a Underweight and lowers the price target from $340 to $240.

CABO

Wells Fargo Maintains Underweight on Cable One, Lowers Price Target to $240

WIIM

Gold is trading lower amid strength in the US dollar and a drop in China's January gold imports.

Deep-pocketed investors have adopted a bearish approach towards Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CAT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Caterpillar. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 55% bearish. Among these notable options, 4 are puts, totaling $171,297, and 5 are calls, amounting to $229,138.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $450.0 for Caterpillar, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Caterpillar options trades today is 190.22 with a total volume of 209.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Caterpillar's big money trades within a strike price range of $145.0 to $450.0 over the last 30 days.
<h3>Caterpillar Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740768390_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$14.15</td>
<td>$12.85</td>
<td>$12.85</td>
<td>$450.00</td>
<td>$64.2K</td>
<td align="right">31</td>
<td align="right">50</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$15.5</td>
<td>$15.2</td>
<td>$15.55</td>
<td>$350.00</td>
<td>$59.0K</td>
<td align="right">254</td>
<td align="right">49</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$20.85</td>
<td>$20.8</td>
<td>$20.85</td>
<td>$330.00</td>
<td>$52.1K</td>
<td align="right">109</td>
<td align="right">27</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$15.8</td>
<td>$15.4</td>
<td>$15.85</td>
<td>$350.00</td>
<td>$41.1K</td>
<td align="right">458</td>
<td align="right">33</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$30.4</td>
<td>$30.25</td>
<td>$30.4</td>
<td>$340.00</td>
<td>$39.5K</td>
<td align="right">582</td>
<td align="right">13</td>
</tr>
</tbody>
</table>

<h3>About Caterpillar</h3>
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy &amp; transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.
In light of the recent options history for Caterpillar, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Caterpillar</h3>
<ul>
<li>Currently trading with a volume of 905,821, the CAT's price is up by 0.04%, now at $340.14. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 55 days.</li>
</ul>
<h3>Expert Opinions on Caterpillar</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $397.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Caterpillar, which currently sits at a price target of $490. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Underweight rating on Caterpillar, which currently sits at a price target of $300. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on Caterpillar, maintaining a target price of $438. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for Caterpillar, targeting a price of $375. 
&#x2A; In a positive move, an analyst from UBS has upgraded their rating to Neutral and adjusted the price target to $385. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Caterpillar options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

Behind the Scenes of Caterpillar's Latest Options Trends

Deep-pocketed investors have adopted a bullish approach towards Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LULU usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Lululemon Athletica. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 30% bearish. Among these notable options, 6 are puts, totaling $197,587, and 7 are calls, amounting to $662,080.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $340.0 and $410.0 for Lululemon Athletica, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Lululemon Athletica options trades today is 281.62 with a total volume of 1,259.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Lululemon Athletica's big money trades within a strike price range of $340.0 to $410.0 over the last 30 days.
<h3>Lululemon Athletica 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740768385_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$62.75</td>
<td>$58.05</td>
<td>$61.16</td>
<td>$360.00</td>
<td>$304.8K</td>
<td align="right">97</td>
<td align="right">49</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$27.25</td>
<td>$26.75</td>
<td>$26.75</td>
<td>$390.00</td>
<td>$115.0K</td>
<td align="right">428</td>
<td align="right">43</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$1.28</td>
<td>$1.11</td>
<td>$1.18</td>
<td>$390.00</td>
<td>$94.4K</td>
<td align="right">124</td>
<td align="right">812</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$49.55</td>
<td>$46.7</td>
<td>$48.75</td>
<td>$390.00</td>
<td>$48.7K</td>
<td align="right">544</td>
<td align="right">10</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$42.95</td>
<td>$38.6</td>
<td>$39.95</td>
<td>$340.00</td>
<td>$39.9K</td>
<td align="right">12</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Lululemon Athletica</h3>
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Having examined the options trading patterns of Lululemon Athletica, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Lululemon Athletica's Current Market Status</h3>
<ul>
<li>With a volume of 547,510, the price of LULU is down -0.33% at $360.96. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>What Analysts Are Saying About Lululemon Athletica</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $500.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Lululemon Athletica with a target price of $500. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lululemon Athletica with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

LULU

Smart Money Is Betting Big In LULU Options

Wells Fargo analyst Vik Chopra maintains Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) with a Equal-Weight and raises the price target from $73 to $75.

SOLV

Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $75

Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $1,135,204 and 7, calls, for a total amount of $483,749.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $60.0 for Moderna over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Moderna stands at 3878.9, with a total volume reaching 3,512.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Moderna, situated within the strike price corridor from $30.0 to $60.0, throughout the last 30 days.
<h3>Moderna Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740768380_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$6.2</td>
<td>$6.0</td>
<td>$6.15</td>
<td>$30.00</td>
<td>$615.0K</td>
<td>1.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.05</td>
<td>$6.95</td>
<td>$7.05</td>
<td>$30.00</td>
<td>$282.0K</td>
<td>13.7K</td>
<td>408</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.75</td>
<td>$2.53</td>
<td>$2.74</td>
<td>$40.00</td>
<td>$134.1K</td>
<td>4.0K</td>
<td>569</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.4</td>
<td>$3.25</td>
<td>$3.4</td>
<td>$45.00</td>
<td>$98.9K</td>
<td>6.6K</td>
<td>7</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.45</td>
<td>$5.35</td>
<td>$5.35</td>
<td>$35.00</td>
<td>$96.2K</td>
<td>7.4K</td>
<td>543</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
<h3>Current Position of Moderna</h3>
<ul>
<li>Currently trading with a volume of 4,492,595, the MRNA's price is down by -2.28%, now at $30.38. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>Expert Opinions on Moderna</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $49.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $78. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Moderna with a target price of $34. 
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $40. 
&#x2A; Reflecting concerns, an analyst from Barclays lowers its rating to Equal-Weight with a new price target of $45.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

MRNA

Moderna Unusual Options Activity

Alkami Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKT#NASDAQ">ALKT</a>) stock gained Friday after Wall Street analysts rerated it after its <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/44036914/alkami-technology-beats-q4-estimates-strengthens-digital-banking-platform-with-400-million-fintech-acquisition" rel="noreferrer noopener">fourth-quarter report</a> on Thursday.
The company reported fourth-quarter revenue of $89.66 million, above&nbsp;the consensus of $89.65 million.
Adjusted EPS of 11 cents exceeded the consensus of 8 cents.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/02/44011152/payoneer-q4-17-revenue-growth-22-5-billion-in-transactions-b2b-payments-up-37-revenue-target-surges" target="_blank" rel="noreferrer noopener">Payoneer Q4: 17% Revenue Growth, $22.5 Billion In Transactions, B2B Payments Up 37%, Revenue Target Surges</a>
Alkami Technology projects a first-quarter revenue of $93.5 million-$95 million compared to the consensus of $95.03 million.
JPMorgan analyst Alexei Gogolev remained Overweight on Alkami Technology with a <a href="https://www.benzinga.com/quote/ALKT/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $45</a>.
Gogolev noted the fourth-quarter results as solid, reflected through robust market share gains. Fiscal 2025E revenue growth and EBITDA on an organic basis were broadly in line with the consensus, implying an impressive 24% growth and five percentage point EBITDA margin expansion to over 13%. 
However, the key focus of today&#8217;s announcement was the acquisition of MANTL, a premier account opening solution, which will help Alkami Technology&#8217;s FIs acquire new customers. The purchase price is equivalent to ~13% of Alkami Technology&#8217;s market cap but will expand its digital user base by 40%, allowing for an even more robust cross-sell opportunity.
The acquisition also turns Alkami Technology into a front-to-back service provider in the digital banking space, providing an opportunity to grab more market share.
Gogolev projected first-quarter revenue of $94 million and adjusted EPS of 9 cents.
Price Action: ALKT stock is up 5.67% at $30.48 at the last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/44008324/echostar-q4-3-97-billion-revenue-narrows-pay-tv-subscriber-losses-focuses-on-high-quality-users-wireless-growth" target="_blank" rel="noreferrer noopener">EchoStar Q4: $3.97 Billion Revenue, Narrows Pay-TV Subscriber Losses, Focuses On High-Quality Users, Wireless Growth</a></li>
</ul>
Image: Shutterstock

Reiteration

Trading Ideas

ALKT

Alkami Growth Accelerates With MANTL Deal, Boosts Digital Banking And Cross-Sell Potential: Analyst

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a>
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week ending Feb. 28:
Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>): The specialty grocery retailer returns to the Stock market Index after appearances in November 2024 <a href="https://www.benzinga.com/25/01/43066466/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">and January 2025</a>. The company recently <a href="https://investors.sprouts.com/news/news-details/2025/Sprouts-Farmers-Market-Inc.-Reports-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx">reported </a>quarterly financial results with earnings per share and revenue each beating Street consensus estimates. The company has beaten both earnings per share and revenue estimates in four straight quarters. Sprouts is guiding for net sales growth of 10.5% to 12.5% in 2025 with comparable store sales growth of 10% to 11% for the full year. Several analysts <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">raised their price targets</a> on the stock after the earnings report. The retailer continues to draw strong interest from investors and unit expansion and net sales growth could continue to boost shares, which are up over 130% in the last year.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339.png" alt="" class="wp-image-804182" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339-768x386.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>): The quantum computing company saw strong interest from readers during the week on the heels <a href="https://www.benzinga.com/news/management/25/02/43993251/ionq-q4-eps-miss-500-million-offering-ceo-appointment-acquires-stake-in-id-quantique-details">of quarterly earnings</a> and a CEO change announcement. The company missed analyst estimates for earnings per share while beating revenue estimates in the quarter. The company has beaten revenue estimates in more than 10 straight quarters.
"We had IonQ's best year yet in 2024, exceeding the high ends of both our bookings and revenue guidance ranges and making truly significant technical strides," IonQ executive chair Peter Chapman said.
Along with quarterly financial results, the company announced an at-the-market equity offering of up to $500 million. The company also announced two agreements with SK Telecom and ID Quantique.
Perhaps the biggest news was the announcement that Chapman will transition from the CEO role to executive chairman with Board of Directors member Niccolo de Masi, who helped take IonQ <a href="https://www.benzinga.com/m-a/21/03/20054892/first-pure-play-quantum-computing-company-comes-public-what-investors-should-know-about-ionq">public via SPAC merger</a>, becoming the company's new president and CEO.
Shares fell on the week, but remain up over 120%. Investors will likely be closely following the next growth story with new leadership as quantum computing remains a hot investment theme.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="510" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340.png" alt="" class="wp-image-804183" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340-768x392.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Keurig Dr Pepper Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>): The beverage company saw strong interest from readers after reporting <a href="https://www.benzinga.com/25/02/43940008/keurig-dr-pepper-q4-earnings-beat-estimates-stock-gains">quarterly financial results</a>. The company's earnings per share beat Street consensus estimates, continuing a trend that includes six beats and four in-line numbers for earnings per share in the last 10 quarters. The company's revenue beat analyst estimates and has now topped analyst estimates in seven of the last 10 quarters. Among the highlights in the report was a 10.3% year-over-year increase for the company's US Refreshment Beverages segment. The beverage company cited strong brand awareness <a href="https://www.benzinga.com/25/02/43966231/keurig-dr-peppers-dirty-soda-success-social-media-fuels-eighth-consecutive-year-of-market-share-growth">on social media </a>and Dr. Pepper hitting market share growth for an eighth consecutive year.
The company also announced a <a href="https://www.benzinga.com/news/25/02/44010283/why-keurig-dr-pepper-kdp-shares-are-falling">secondary public offering</a> of 73 million shares through a subsidiary of JAB Holding Company. After the offering, JAB will hold around 10.7% of KDP's outstanding stock. The sale could dilute shares and also signal that JAB believes shares are fairly valued or overvalued.
Several analysts<a href="https://www.benzinga.com/quote/KDP/analyst-ratings"> raised their price targets</a> on the beverage stock after the earnings report.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="507" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341.png" alt="" class="wp-image-804184" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341-768x389.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>): The residential REIT saw strong interest from readers during the week, which comes after the company announced an<a href="https://www.benzinga.com/news/large-cap/25/02/43917549/sun-communities-reaps-5-65-billion-from-safe-harbor-sale-refines-strategy"> agreement to sell </a>its interest in Safe Harbor Marinas to an affiliate of Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>). The deal will bring in proceeds of $5.5 billion after costs for Sun Communities, which the company plans to use towards debt reduction, investments in core businesses and for shareholder distributions.
An owner of manufactured homes, RV parks and marina properties, the transaction will see manufactured homes and RVs represent around 90% of the company's net operating income.
"This transaction allows Sun to focus on our core businesses which operate at high margins and produce durable income streams," Sun's Capital Allocation Committee Chair Jeff Blau said.
After the announced transaction, the company <a href="https://suncommunities.gcs-web.com/news-releases/news-release-details/sun-communities-reports-2024-fourth-quarter-and-full-year">reported </a>fourth-quarter financial results with FFO missing analyst estimates for a third straight quarter and revenue beating estimates. The company has beaten analyst revenue estimates in eight of the last 10 quarters.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342.png" alt="" class="wp-image-804185" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342-768x387.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Liberty Formula One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>): The owner of the Formula 1 racing league saw strong interest from investors during the week. The company has several upcoming catalysts including the <a href="https://x.com/netflix/status/1895504704488030389">launch </a>of the seventh season of "F1: Drive to Survive" on Netflix on March 7 and the start of the new 2025 season on March 14. The racing league is also drawing interest from Netflix for the <a href="https://www.benzinga.com/25/02/43816739/netflix-wants-more-nfl-games-after-christmas-day-success-could-league-create-bidding-war-with-cbs-fox">potential media rights</a> in the U.S. when a current deal with ESPN expires. A new American Formula 1 team will be part of <a href="https://www.benzinga.com/general/sports/24/11/42178255/formula-1-stock-hits-52-week-high-announces-11th-team-with-general-motorsandretti-global-after-max-verstappens-fourth-straight-title">the 2026 season </a>and could increase awareness for the global sports brand in the coming years. The Netflix docuseries and American race locations have helped increase viewership and awareness in the United States, a trend the league hopes will continue.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343.png" alt="" class="wp-image-804186" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343-768x386.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43201590/benzinga-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-2" target="_blank" rel="noreferrer noopener">January 24</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43419547/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-52" target="_blank" rel="noreferrer noopener">January 31</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43578212/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-53" target="_blank" rel="noreferrer noopener">February 7</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43900861/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-54">February 21 </a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a></li>
</ul>
Photo: Benzinga

Exclusives

FWONA

FWONK

IONQ

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Wells Fargo analyst Neil Kalton maintains Edison Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) with a Overweight and lowers the price target from $94 to $75.

Wells Fargo Maintains Overweight on Edison Intl, Lowers Price Target to $75

Wells Fargo analyst Finian O'Shea maintains Trinity Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIN#NASDAQ">TRIN</a>) with a Underweight and raises the price target from $13 to $14.

TRIN

Wells Fargo Maintains Underweight on Trinity Cap, Raises Price Target to $14

WW international shares are trading lower. The company reported Q4 financial results.

Wells Fargo analyst Finian O'Shea maintains BlackRock TCP Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCPC#NASDAQ">TCPC</a>) with a Underweight and lowers the price target from $8 to $7.5.

TCPC

Wells Fargo Maintains Underweight on BlackRock TCP Cap, Lowers Price Target to $7.5

Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDRX#NASDAQ">GDRX</a>) with a Overweight and lowers the price target from $9 to $8.

GDRX

Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $8

Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>) with a Equal-Weight and lowers the price target from $214 to $146.

Wells Fargo Maintains Equal-Weight on Teleflex, Lowers Price Target to $146

President Donald Trump and Vice President JD Vance engaged in a tense exchange with Ukrainian President Volodymyr Zelenskyy during a White House meeting, where discussions on <a href="https://www.benzinga.com/topic/ukraine">military aid and diplomacy</a> took a confrontational turn. 
The gathering, originally set to finalize a U.S.-Ukraine agreement on critical mineral supplies, quickly escalated when Vance accused Zelenskyy of being disrespectful. Trump, raising his voice, warned Zelenskyy that he was &#8220;gambling with World War III,&#8221; as CNBC <a href="https://www.cnbc.com/2025/02/28/trump-vance-and-zelenskyy-clash-at-white-house-ukraine-meeting.html">reports</a>.
What Happened: Zelenskyy's visit to Washington, D.C., was expected to reinforce Ukraine's partnership with the U.S. in its ongoing defense efforts against Russian aggression. However, the dialogue shifted when Trump and Vance questioned Ukraine's diplomatic strategies, with Vance suggesting that prior U.S. policies had only fueled further conflict. 
Zelenskyy countered by emphasizing Russia's repeated breaches of ceasefire agreements, leading to a heated back-and-forth over what path forward would bring about peace.
Trump pushed back against Zelenskyy's warnings about future global instability, telling him, &#8220;You're in no position to dictate what we're gonna feel.&#8221; 
The dramatic moment underscored the friction in U.S. foreign policy discussions under the Trump administration, particularly regarding military aid and negotiations with Russia.
Also Read: <a href="https://www.benzinga.com/markets/25/02/44034579/trump-plans-big-deals-to-offset-chinas-belt-and-road-initiative-the-us-wants-to-reverse-all-of-that-says-rubio">Trump Plans &#8216;Big Deals&#8217; To Offset China&#8217;s Belt And Road Initiative: US Wants To &#8216;Reverse All Of That&#8217;, Says Rubio</a>
Why It Matters: The confrontation highlights a growing divide in how U.S. leaders approach support for Ukraine, with Trump and Vance advocating for alternative diplomatic solutions while Zelenskyy pushes for continued backing against Russian forces. 
The debate over military assistance and diplomatic engagement remains at the forefront of international security concerns, shaping NATO strategies and influencing global defense spending.
Amid these developments, U.K. Prime Minister Keir Starmer's recent visit to Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) in Washington, D.C., reflects a broader push for AI-driven defense initiatives in response to the ongoing Russia-Ukraine conflict. Starmer, alongside Trump, announced significant increases in military budgets, reinforcing the strategic alignment between the U.S. and the U.K. on <a href="https://www.benzinga.com/markets/equities/25/02/44032909/palantir-ceo-alex-karp-meets-keir-starmer-as-uk-pm-and-trump-push-for-increased-defense-spending-amid-ukraine-war">defense technology investments</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44049626/key-inflation-measure-falls-in-january-should-catch-the-feds-attention-expert-says">Key Inflation Measure Falls In January: &#8216;Should Catch The Fed&#8217;s Attention,&#8217; Economist Says</a></li>
</ul>
Image created using Shutterstock photos.

Eurozone

PLTR

White House Meeting Turns Tense As Trump Warns Zelenskyy: 'You're Gambling With World War III'

Wells Fargo analyst Neil Kalton maintains FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) with a Equal-Weight and lowers the price target from $48 to $41.

Comments

Ascend Wellness Holdings

Notizie

Ultime notizie per Ascend Wellness Holdings (OTC:AAWH) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO